Radhakrishnan Nerukav V, Shenoy Achuth H, Cartmill Ivor, Sharma Ravi K, George Regi, Foster David N, Quest Laura
Department of Gastroenterology, Rochdale Infirmary, Pennine Acute Hospitals' NHS Trust, Rochdale, UK.
Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1279-84. doi: 10.1097/01.meg.0000243871.48831.00.
To study the effectiveness of local antiseptic spray with or without a three-dose antibiotic regimen in the prevention of stomal infection following percutaneous endoscopic gastrostomy.
Ninety-six patients were randomized into three groups: A, intravenous cefuroxime 750 mg just before the procedure followed by two further doses every 8 h; B, single application of povidone-iodine (Betadine) antiseptic spray; C, combination of A and B. The stomal site was examined at midweek and at the end of week 1 for evidence of infection using a validated scoring system. Fisher's exact test was used for analysis of primary end point, namely, stomal infection at midweek and at the end of week 1. Logistic regression models were used for secondary analysis to consider the effects of diabetes, acid suppressants, steroids, age and sex on outcome.
Group A had 34 patients, group B had 28 and group C had 34. Age, sex and indications in groups A, B and C are broadly comparable. Stomal infection was 32% in group B vs. groups A (6%) and C (9%) (P = 0.0114) at midweek, and 3% in group C vs. 32% each in groups A and B (P = 0.0013) at the end of week 1. Cumulative infections (n) at the end of week 1 were lower in group C (3) (9%) than in groups A (11) (32%) and B (12) (43%) (P = 0.003). No significant difference was observed between the three groups in terms of the number of patients who were given antibiotics for other indications (P = 0.363). By logistic regression only diabetes, but not other covariates, seems to have a significant effect on stomal infection (odds ratio, 33.34; 95% CI, 4.33-256.7).
A combination of cefuroxime and Betadine spray significantly reduces stomal infection following percutaneous endoscopic gastrostomy at the end of week 1. Both the antibiotic group (A) and the combined group (C) did well compared with the Betadine only group (B) at midweek.
研究局部使用抗菌喷雾剂联合或不联合三剂量抗生素方案在预防经皮内镜下胃造口术后造口感染中的有效性。
96例患者被随机分为三组:A组,术前静脉注射750mg头孢呋辛,随后每8小时再注射两剂;B组,单次应用聚维酮碘(碘伏)抗菌喷雾剂;C组,A组和B组联合使用。在第周中和第1周结束时,使用经过验证的评分系统检查造口部位是否有感染迹象。采用Fisher精确检验分析主要终点,即第周中和第1周结束时的造口感染情况。使用逻辑回归模型进行二次分析,以考虑糖尿病、抑酸剂、类固醇、年龄和性别对结果的影响。
A组有34例患者,B组有28例,C组有34例。A、B、C三组的年龄、性别和适应症大致相当。在第周中,B组的造口感染率为32%,而A组(6%)和C组(9%)(P = 0.0114);在第1周结束时,C组的感染率为3%,而A组和B组均为32%(P = 0.0013)。第1周结束时,C组的累积感染数(n)为3例(9%),低于A组的11例(32%)和B组的12例(43%)(P = 0.003)。三组中因其他适应症接受抗生素治疗的患者数量无显著差异(P = 0.363)。通过逻辑回归分析,只有糖尿病而非其他协变量似乎对造口感染有显著影响(比值比,33.34;95%可信区间,4.33 - 256.7)。
头孢呋辛和碘伏喷雾剂联合使用可显著降低经皮内镜下胃造口术后第1周结束时的造口感染率。在第周中,抗生素组(A组)和联合组(C组)与仅使用碘伏组(B组)相比效果良好。